CN1206267C - 基于聚乙烯醇的薄膜包衣和薄膜包衣组合物 - Google Patents
基于聚乙烯醇的薄膜包衣和薄膜包衣组合物 Download PDFInfo
- Publication number
- CN1206267C CN1206267C CNB008100950A CN00810095A CN1206267C CN 1206267 C CN1206267 C CN 1206267C CN B008100950 A CNB008100950 A CN B008100950A CN 00810095 A CN00810095 A CN 00810095A CN 1206267 C CN1206267 C CN 1206267C
- Authority
- CN
- China
- Prior art keywords
- dispersion
- scope
- content
- fluid film
- film dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 81
- 239000004372 Polyvinyl alcohol Substances 0.000 title claims abstract description 72
- 229920002451 polyvinyl alcohol Polymers 0.000 title claims abstract description 72
- 239000007888 film coating Substances 0.000 title claims abstract description 44
- 238000009501 film coating Methods 0.000 title claims abstract description 44
- 239000006185 dispersion Substances 0.000 claims abstract description 88
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 51
- 239000000049 pigment Substances 0.000 claims abstract description 46
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 42
- 238000000576 coating method Methods 0.000 claims abstract description 32
- 239000011248 coating agent Substances 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 25
- 235000011187 glycerol Nutrition 0.000 claims abstract description 21
- 235000009508 confectionery Nutrition 0.000 claims abstract description 10
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 82
- 239000012530 fluid Substances 0.000 claims description 71
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 41
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 41
- -1 polyoxyethylene Polymers 0.000 claims description 41
- 239000000470 constituent Substances 0.000 claims description 39
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 31
- 230000007062 hydrolysis Effects 0.000 claims description 26
- 238000006460 hydrolysis reaction Methods 0.000 claims description 26
- 239000004902 Softening Agent Substances 0.000 claims description 20
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 14
- 239000011118 polyvinyl acetate Substances 0.000 claims description 14
- 239000011159 matrix material Substances 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 abstract description 17
- 239000000758 substrate Substances 0.000 abstract description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 235000010445 lecithin Nutrition 0.000 abstract 2
- 229940067606 lecithin Drugs 0.000 abstract 2
- 239000000787 lecithin Substances 0.000 abstract 2
- 239000003605 opacifier Substances 0.000 abstract 2
- 239000004014 plasticizer Substances 0.000 abstract 2
- 239000000454 talc Substances 0.000 abstract 2
- 229910052623 talc Inorganic materials 0.000 abstract 2
- 239000010408 film Substances 0.000 description 40
- 239000003826 tablet Substances 0.000 description 24
- 239000007921 spray Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 238000005507 spraying Methods 0.000 description 7
- 230000002045 lasting effect Effects 0.000 description 6
- 239000012748 slip agent Substances 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000002198 insoluble material Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229960001404 quinidine Drugs 0.000 description 2
- 239000002195 soluble material Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical group [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000000989 food dye Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/34—Silicon-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/49—Phosphorus-containing compounds
- C08K5/51—Phosphorus bound to oxygen
- C08K5/52—Phosphorus bound to oxygen only
- C08K5/521—Esters of phosphoric acids, e.g. of H3PO4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- General Preparation And Processing Of Foods (AREA)
- Paints Or Removers (AREA)
- Confectionery (AREA)
Abstract
Description
Claims (54)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/351,076 US6448323B1 (en) | 1999-07-09 | 1999-07-09 | Film coatings and film coating compositions based on polyvinyl alcohol |
US09/351,076 | 1999-07-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1360612A CN1360612A (zh) | 2002-07-24 |
CN1206267C true CN1206267C (zh) | 2005-06-15 |
Family
ID=23379470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008100950A Expired - Lifetime CN1206267C (zh) | 1999-07-09 | 2000-06-30 | 基于聚乙烯醇的薄膜包衣和薄膜包衣组合物 |
Country Status (20)
Country | Link |
---|---|
US (1) | US6448323B1 (zh) |
EP (1) | EP1208143B1 (zh) |
JP (2) | JP2003509339A (zh) |
KR (1) | KR100616732B1 (zh) |
CN (1) | CN1206267C (zh) |
AR (1) | AR025542A1 (zh) |
AT (1) | ATE272674T1 (zh) |
AU (1) | AU766046B2 (zh) |
BR (1) | BR0012263B1 (zh) |
CA (1) | CA2374629C (zh) |
CO (1) | CO5190675A1 (zh) |
CZ (1) | CZ303912B6 (zh) |
DE (1) | DE60012754T2 (zh) |
EG (1) | EG24436A (zh) |
ES (1) | ES2225209T3 (zh) |
HU (1) | HU226963B1 (zh) |
IL (2) | IL147425A0 (zh) |
TW (1) | TWI288162B (zh) |
WO (1) | WO2001004195A1 (zh) |
ZA (1) | ZA200200104B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102421421A (zh) * | 2009-05-12 | 2012-04-18 | Bpsi控股有限责任公司 | 含有抗黏性剂细微颗粒的包衣和覆有该包衣的基体 |
CN107259580A (zh) * | 2017-07-17 | 2017-10-20 | 武汉维奥制药有限公司 | 一种多种矿物质维生素制剂的制备方法 |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9720061D0 (en) * | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
JP2002241797A (ja) * | 2001-02-20 | 2002-08-28 | Kao Corp | 洗濯用物品 |
US6550539B2 (en) * | 2001-06-20 | 2003-04-22 | Weatherford/Lamb, Inc. | Tie back and method for use with expandable tubulars |
DE10207427A1 (de) | 2002-02-21 | 2003-09-04 | Basf Ag | Schnelllöslicher Filmüberzug basierend auf Polyvinylalkohol-Polyether-Pfropfcopolymeren in Kombination mit Hydroxy-, Amid-, oder Esterfunktionen enthaltenden Komponenten |
DE10211195B4 (de) * | 2002-03-11 | 2009-01-02 | Ipc Process Center Gmbh | Nahrungsergänzungsmittel |
JP4549609B2 (ja) * | 2002-04-11 | 2010-09-22 | エスエス製薬株式会社 | 被覆固形催眠製剤 |
US8956160B2 (en) * | 2002-07-02 | 2015-02-17 | Ranir, Llc | Device and method for delivering an oral care agent |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
DE10248619A1 (de) * | 2002-10-18 | 2004-04-29 | Bayer Ag | Verfahren zur Herstellung pulverförmiger Wirkstoff-Formulierungen mit kompressiblen Fluiden |
SI21402A (sl) | 2003-02-12 | 2004-08-31 | LEK farmacevtska dru�ba d.d. | Obloženi delci in farmacevtske oblike |
WO2005019286A1 (ja) * | 2003-08-20 | 2005-03-03 | Shionogi & Co., Ltd. | 新規コーティング組成物 |
EP1512331B1 (de) * | 2003-09-02 | 2007-11-21 | IPC Process Center GmbH & Co. | Nahrungsergänzungsmittel |
WO2005055741A1 (de) * | 2003-12-12 | 2005-06-23 | Basf Aktiengesellschaft | Verfahren und mittel für die oberflächenbehandlung von lebensmitteln |
WO2005089719A1 (en) * | 2004-02-25 | 2005-09-29 | Ideal Cures Pvt.Ltd. | Polish compositions |
DE102004031835A1 (de) | 2004-06-30 | 2006-01-19 | Basf Ag | Schnelldispergierbares, feinteiliges, nicht zur Entmischung neigendes pulverförmiges Filmüberzugsmittel basierend auf Polyvinylalkohol-Polyether-Pfropfcopolymeren gekennzeichnet durch besondere physikalische Stabilität und niedrige Rauhigkeit |
US20060088587A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060088586A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060088593A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060087051A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20070281022A1 (en) * | 2004-10-27 | 2007-12-06 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20070190133A1 (en) * | 2004-10-27 | 2007-08-16 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US8383159B2 (en) * | 2004-10-27 | 2013-02-26 | Mcneil-Ppc, Inc. | Dosage forms having a microreliefed surface and methods and apparatus for their production |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
US20080096979A1 (en) * | 2004-11-08 | 2008-04-24 | Rubicon Research Pvt. Ltd. | Aqueous Pharmaceutical Coating |
US20060099550A1 (en) * | 2004-11-10 | 2006-05-11 | Ranir/Dcp Corporation | Device and method for delivering an oral care agent |
WO2006121803A1 (en) | 2005-05-05 | 2006-11-16 | Sensient Flavors Inc. | Production of beta-glucans and mannans |
US8192845B2 (en) * | 2005-11-04 | 2012-06-05 | Cargill, Incorported | Lecithin-containing starch compositions, preparation thereof and paper products having oil and grease resistance, and/or release properties |
US7931778B2 (en) | 2005-11-04 | 2011-04-26 | Cargill, Incorporated | Lecithin-starches compositions, preparation thereof and paper products having oil and grease resistance, and/or release properties |
MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
JPWO2007126039A1 (ja) * | 2006-04-28 | 2009-09-10 | 塩野義製薬株式会社 | マクロライド系抗生物質の被覆製剤 |
EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
CA2810522A1 (en) | 2006-05-04 | 2007-11-15 | Boehringer Ingelheim International Gmbh | Polymorphs |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
WO2008042802A2 (en) * | 2006-09-29 | 2008-04-10 | Sensient Pharmaceutical Technologies Inc. | Wet edible pearlescent film coatings |
ES2592716T3 (es) | 2006-12-14 | 2016-12-01 | Sensient Colors Llc | Composiciones de pigmento nacarado y métodos para realizar y usar las mismas |
JP5162141B2 (ja) * | 2007-02-20 | 2013-03-13 | エスエス製薬株式会社 | フィルムコーティング用組成物 |
CA2684173C (en) * | 2007-04-26 | 2015-06-30 | Eisai R&D Management Co., Ltd. | Process for production of tablet |
GB0714670D0 (en) * | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) * | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
US9101131B2 (en) | 2007-12-03 | 2015-08-11 | Valent U.S.A., Corporation | Seed treatment formulations |
PT2271348T (pt) | 2008-03-28 | 2018-04-16 | Paratek Pharm Innc | Formulação de comprimido oral de composto de tetraciclina |
PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
KR20190016601A (ko) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
WO2010056833A1 (en) * | 2008-11-12 | 2010-05-20 | Archer Daniels Midland Company | Lecithin and plasticizer compositions and methods |
US10294376B2 (en) * | 2008-11-12 | 2019-05-21 | Archer Daniels Midland Company | Lecithin and plasticizer compositions and methods |
EP2193710B1 (en) * | 2008-12-05 | 2014-04-09 | Patent 06-001 B.V. | Coating for lily bulbs |
DK2395983T3 (da) | 2009-02-13 | 2020-07-13 | Boehringer Ingelheim Int | Farmaceutisk sammensætning omfattende en sglt2-inhibitor, en dpp-iv-inhibitor og eventuelt et yderligere antidiabetisk middel og anvendelser deraf |
SI2398468T1 (sl) | 2009-02-17 | 2017-03-31 | Krka, D.D., Novo Mesto | Farmacevtske sestave, ki obsegajo prasugrel ali njegove farmacevtsko sprejemljive kislinske adicijske soli in postopek za njihovo pripravo |
TWI455733B (zh) | 2009-03-30 | 2014-10-11 | Toray Industries | 口腔內崩壞性被覆錠劑 |
CN102421423B (zh) | 2009-05-12 | 2014-11-05 | Bpsi控股有限责任公司 | 增强型防潮即释薄膜包衣系统和覆有该包衣的基体 |
GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
ES2760917T3 (es) | 2009-11-27 | 2020-05-18 | Boehringer Ingelheim Int | Tratamiento de pacientes diabéticos genotipificados con inhibidores DPP-IV como la linagliptina |
EP2512457B1 (de) | 2009-12-16 | 2015-10-28 | Basf Se | Filmüberzugsmittel basierend auf polyvinylalkohol-polyether-pfropfcopolymeren- polyvinylalkohol-kombinationen mit verbesserter feuchtigkeitsbarrierewirkung |
US8414905B2 (en) | 2009-12-16 | 2013-04-09 | Basf Se | Film coating compositions based on polyvinyl alcohol-polyether graft copolymer/polyvinyl alcohol combinations with an improved moisture barrier effect |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
JP6034781B2 (ja) | 2010-05-05 | 2016-11-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 併用療法 |
BR112013000903B1 (pt) * | 2010-08-31 | 2019-12-03 | Toray Industries | agente de revestimento para uma preparação sólida farmacêutica, formulação de filme farmacêutica, e, preparação sólida farmacêutica revestida |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
US8715729B2 (en) | 2010-12-22 | 2014-05-06 | Basf Se | Rapidly disintegrating, solid coated dosage form |
AR085689A1 (es) | 2011-03-07 | 2013-10-23 | Boehringer Ingelheim Int | Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2 |
US8883800B2 (en) | 2011-07-15 | 2014-11-11 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
US20130156855A1 (en) * | 2011-12-16 | 2013-06-20 | Aviv Ben-Menachem | Acne treatment |
SG11201403564YA (en) * | 2011-12-27 | 2014-07-30 | Celgene Corp | Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione |
JP5916091B2 (ja) * | 2012-01-31 | 2016-05-11 | 大原薬品工業株式会社 | 口腔内崩壊錠のuvレーザー印刷方法 |
US9555001B2 (en) * | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
EP2849755A1 (en) | 2012-05-14 | 2015-03-25 | Boehringer Ingelheim International GmbH | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
WO2014030204A1 (ja) * | 2012-08-20 | 2014-02-27 | 大日本住友製薬株式会社 | 薬物含有中空粒子 |
AT513519B1 (de) | 2012-10-23 | 2014-07-15 | Gebro Holding Gmbh | Filmbeschichtungszusammensetzung |
CN105120666A (zh) | 2013-02-22 | 2015-12-02 | 美商华仑公司 | 种子处理制剂 |
EP2970640A1 (en) * | 2013-03-13 | 2016-01-20 | Celanese Acetate LLC | Cellulose diester films for playing cards |
US9675587B2 (en) | 2013-03-14 | 2017-06-13 | Allergan Holdings Unlimited Company | Opioid receptor modulator dosage formulations |
FR3004070B1 (fr) * | 2013-04-05 | 2015-07-31 | Bel Fromageries | Procede d'enrobage de produits fromagers |
TWI642768B (zh) | 2013-06-04 | 2018-12-01 | 蒙諾蘇爾有限公司 | 水溶性膜之密封溶液、相關方法及相關物品 |
EP2810644A1 (en) | 2013-06-06 | 2014-12-10 | Ferrer Internacional, S.A. | Oral formulation for the treatment of cardiovascular diseases |
JP2016531151A (ja) * | 2013-09-13 | 2016-10-06 | バイエル ファーマ アクチエンゲゼルシャフト | レファメチニブを含有する医薬組成物 |
CA2933202C (en) | 2014-01-21 | 2022-05-31 | Jason Teckoe | Immediate release film coatings containing medium chain glycerides and substrates coated therewith |
EP2774606B1 (en) * | 2014-02-14 | 2019-01-30 | Synthon B.V. | Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV |
EP3110449B1 (en) | 2014-02-28 | 2023-06-28 | Boehringer Ingelheim International GmbH | Medical use of a dpp-4 inhibitor |
US10047477B2 (en) * | 2014-04-02 | 2018-08-14 | Kraton Polymers U.S. Llc | Textile coating composition |
CN103948672B (zh) * | 2014-05-05 | 2020-06-12 | 南宁富莱欣生物科技有限公司 | 一种包衣片剂及其生产方法 |
ES2951884T3 (es) | 2015-01-01 | 2023-10-25 | Ideal Cures Pvt Ltd | Novedosa composición de recubrimiento de película |
AU2016248017A1 (en) * | 2015-04-16 | 2017-10-19 | Novartis Ag | Ribociclib tablet |
CN107708429A (zh) * | 2015-04-24 | 2018-02-16 | 国际香料和香精公司 | 递送体系及其制备方法 |
FR3044678B1 (fr) * | 2015-12-04 | 2017-12-08 | Eurotab | Tablette detergente enrobee |
KR101950907B1 (ko) * | 2016-02-05 | 2019-02-21 | 한국유나이티드제약 주식회사 | 지용성 약물 및 방유성 기제가 코팅된 고형제제를 포함하는 경구용 복합제제 |
KR102158339B1 (ko) * | 2016-02-05 | 2020-09-21 | 삼진제약주식회사 | 인습성이 개선된 카르베딜롤 속방성 제제 |
JP2019517542A (ja) | 2016-06-10 | 2019-06-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | リナグリプチンおよびメトホルミンの組合せ |
JP7189689B2 (ja) * | 2018-06-25 | 2022-12-14 | 日本酢ビ・ポバール株式会社 | コーティング組成物並びに経口固形剤及びその製造方法 |
US11168485B2 (en) | 2018-09-15 | 2021-11-09 | VBBT Corp. | Low cost emergency housing |
GB201918030D0 (en) * | 2019-12-09 | 2020-01-22 | Synthomer Uk Ltd | Improvements in, or relating to, binders and/or coatings |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1216486B (de) * | 1964-04-23 | 1966-05-12 | Merck Ag E | Verfahren zur Herstellung von Dragees |
US3935326A (en) * | 1967-06-28 | 1976-01-27 | Boehringer Mannheim G.M.B.H. | Process for coating tablets with aqueous resin dispersions |
US4060598A (en) * | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
JPS5428812A (en) | 1977-08-09 | 1979-03-03 | Yoshitomi Pharmaceut Ind Ltd | Preparation of coated tablet |
JPS5549312A (en) | 1978-10-03 | 1980-04-09 | Sankyo Co Ltd | Preparation of slow-releasing medicine |
US4543370A (en) | 1979-11-29 | 1985-09-24 | Colorcon, Inc. | Dry edible film coating composition, method and coating form |
US4683256A (en) | 1980-11-06 | 1987-07-28 | Colorcon, Inc. | Dry edible film coating composition, method and coating form |
US4432965A (en) * | 1982-07-09 | 1984-02-21 | Key Pharmaceuticals, Inc. | Quinidine sustained release dosage formulation |
JPS5942325A (ja) | 1982-09-03 | 1984-03-08 | Dai Ichi Seiyaku Co Ltd | コ−テイング用組成物及びコ−テイング製剤 |
FR2548675B1 (fr) * | 1983-07-06 | 1987-01-09 | Seppic Sa | Compositions filmogenes pour enrobage des formes solides de produits pharmaceutiques ou alimentaires et produits obtenus revetus desdites compositions |
JP3059200B2 (ja) * | 1990-09-27 | 2000-07-04 | 株式会社クラレ | 易崩壊性樹脂組成物 |
TW235239B (zh) * | 1992-11-20 | 1994-12-01 | Pfizer | |
FR2698560B1 (fr) * | 1992-11-30 | 1995-02-03 | Virbac Laboratoires | Principes actifs pulvérulents stabilisés, compositions les contenant, leur procédé d'obtention et leurs applications. |
US5322866A (en) * | 1993-01-29 | 1994-06-21 | The United States Of America As Represented By The Secretary Of The Army | Method of producing biodegradable starch-based product from unprocessed raw materials |
GB9414045D0 (en) * | 1994-07-12 | 1994-08-31 | Berwind Pharma Service | Moisture barrier film coating composition, method, and coated form |
CZ297271B6 (cs) * | 1994-07-12 | 2006-10-11 | Bpsi Holdings, Inc. | Suchá povlaková hmota pro výrobu filmu zabranujícímu prístupu vlhkosti, zpusob a tvorba povlaku |
JP3274573B2 (ja) | 1994-08-25 | 2002-04-15 | 興和株式会社 | フィルムコーティング組成物およびそれを用いた固形製剤 |
JPH092976A (ja) * | 1995-06-20 | 1997-01-07 | Lion Corp | 被覆組成物 |
US5789014A (en) * | 1995-12-25 | 1998-08-04 | Shin-Etsu Chemical Co., Ltd. | Method of manufacturing a solid preparation coated with non-solvent coating |
-
1999
- 1999-07-09 US US09/351,076 patent/US6448323B1/en not_active Expired - Lifetime
-
2000
- 2000-06-30 CN CNB008100950A patent/CN1206267C/zh not_active Expired - Lifetime
- 2000-06-30 WO PCT/US2000/040287 patent/WO2001004195A1/en active IP Right Grant
- 2000-06-30 DE DE60012754T patent/DE60012754T2/de not_active Expired - Lifetime
- 2000-06-30 HU HU0202260A patent/HU226963B1/hu unknown
- 2000-06-30 EP EP00960118A patent/EP1208143B1/en not_active Expired - Lifetime
- 2000-06-30 AU AU71328/00A patent/AU766046B2/en not_active Expired
- 2000-06-30 ES ES00960118T patent/ES2225209T3/es not_active Expired - Lifetime
- 2000-06-30 IL IL14742500A patent/IL147425A0/xx active IP Right Grant
- 2000-06-30 JP JP2001509406A patent/JP2003509339A/ja active Pending
- 2000-06-30 CZ CZ20020066A patent/CZ303912B6/cs not_active IP Right Cessation
- 2000-06-30 CA CA002374629A patent/CA2374629C/en not_active Expired - Lifetime
- 2000-06-30 BR BRPI0012263-7A patent/BR0012263B1/pt not_active IP Right Cessation
- 2000-06-30 AT AT00960118T patent/ATE272674T1/de not_active IP Right Cessation
- 2000-06-30 KR KR1020027000241A patent/KR100616732B1/ko not_active IP Right Cessation
- 2000-07-02 EG EG20000866A patent/EG24436A/xx active
- 2000-07-04 AR ARP000103405A patent/AR025542A1/es active IP Right Grant
- 2000-07-07 TW TW089113503A patent/TWI288162B/zh not_active IP Right Cessation
- 2000-07-07 CO CO00051041A patent/CO5190675A1/es not_active Application Discontinuation
-
2001
- 2001-12-31 IL IL147425A patent/IL147425A/en unknown
-
2002
- 2002-01-04 ZA ZA200200104A patent/ZA200200104B/xx unknown
-
2011
- 2011-05-26 JP JP2011118152A patent/JP2011225576A/ja active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102421421A (zh) * | 2009-05-12 | 2012-04-18 | Bpsi控股有限责任公司 | 含有抗黏性剂细微颗粒的包衣和覆有该包衣的基体 |
CN107259580A (zh) * | 2017-07-17 | 2017-10-20 | 武汉维奥制药有限公司 | 一种多种矿物质维生素制剂的制备方法 |
CN107259580B (zh) * | 2017-07-17 | 2018-06-19 | 武汉维奥制药有限公司 | 一种多种矿物质维生素制剂的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
ES2225209T3 (es) | 2005-03-16 |
BR0012263B1 (pt) | 2010-11-16 |
CZ200266A3 (cs) | 2002-07-17 |
ATE272674T1 (de) | 2004-08-15 |
CN1360612A (zh) | 2002-07-24 |
EG24436A (en) | 2009-06-25 |
KR100616732B1 (ko) | 2006-08-28 |
EP1208143B1 (en) | 2004-08-04 |
WO2001004195A8 (en) | 2001-10-04 |
IL147425A0 (en) | 2002-08-14 |
CO5190675A1 (es) | 2002-08-29 |
AU7132800A (en) | 2001-01-30 |
CZ303912B6 (cs) | 2013-06-26 |
JP2003509339A (ja) | 2003-03-11 |
AR025542A1 (es) | 2002-12-04 |
WO2001004195A1 (en) | 2001-01-18 |
CA2374629C (en) | 2009-05-19 |
JP2011225576A (ja) | 2011-11-10 |
DE60012754T2 (de) | 2005-09-01 |
AU766046B2 (en) | 2003-10-09 |
CA2374629A1 (en) | 2001-01-18 |
ZA200200104B (en) | 2003-06-25 |
US6448323B1 (en) | 2002-09-10 |
US20020103285A1 (en) | 2002-08-01 |
EP1208143A4 (en) | 2002-10-30 |
BR0012263A (pt) | 2002-03-12 |
DE60012754D1 (de) | 2004-09-09 |
HU226963B1 (en) | 2010-03-29 |
HUP0202260A2 (en) | 2002-11-28 |
EP1208143A1 (en) | 2002-05-29 |
IL147425A (en) | 2006-08-01 |
KR20020029073A (ko) | 2002-04-17 |
TWI288162B (en) | 2007-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1206267C (zh) | 基于聚乙烯醇的薄膜包衣和薄膜包衣组合物 | |
CN1097619C (zh) | 隔潮膜涂层组合物及其生产方法以及涂层制品 | |
CN1223341C (zh) | 球形体、其制备方法以及药物组合物 | |
CN1065263C (zh) | 干薄膜涂料组合物及其制备方法和用途 | |
CN1212833C (zh) | 苯并咪唑衍生物的口服给药的药物制剂及其制备方法 | |
CN1103643C (zh) | 基于糊精的涂膜及涂膜组合物 | |
CN1247190C (zh) | 具有难溶性药物速释片芯的缓释包衣片 | |
CN1051225C (zh) | 稳定的胃酸耐受奥美拉唑微粒组合物及其制备方法 | |
CN1250101C (zh) | 涂覆聚合物的、粒状含酶饲料添加剂及其制备方法 | |
EP2220157B1 (en) | Cellulose ether coating compositions and method | |
CN1198600C (zh) | 可食用的mcc/pga包衣组合物 | |
CN1080169A (zh) | 含有水溶性药物的控释片 | |
CN1338926A (zh) | 可食用的包衣组合物 | |
CN100337687C (zh) | 含有γ-氨基丁酸衍生物的固体组合物及其制备方法 | |
CN1045921A (zh) | 直接压制的考来烯胺片及其无溶剂包衣 | |
CN86107734A (zh) | 药物的制备 | |
CN1589139A (zh) | 调节释放坦洛新片剂 | |
CN1684665A (zh) | 包含替米沙坦的固体药用制剂 | |
CN1197574C (zh) | 稳定苯并咪唑化合物的方法 | |
CN1388189A (zh) | 含有纤维素醚的浸涂组合物 | |
CN1388190A (zh) | 含有淀粉或糊精的浸涂组合物 | |
CN1813804A (zh) | 六神外用膏剂及其制备方法 | |
CN1589156A (zh) | 含有对酸不稳定的生理活性化合物的制剂组合物及其制法 | |
CN1676543A (zh) | 粘土及其制造方法和制作物 | |
CN1713896A (zh) | 球形体、其制备方法以及药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
C10 | Entry into substantive examination | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BPSI HOLDINGS LLC Free format text: FORMER OWNER: BERWIND PHARMACEUTICAL SERVICES, INC. Effective date: 20021107 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20021107 Address after: Delaware Applicant after: BPSI Holdings Inc. Address before: American Pennsylvania Applicant before: Berwind Pharmaceutical Services, Inc. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BPSI HOLDING CO., LTD. Free format text: FORMER OWNER: BPSI HOLDINGS LLC Effective date: 20081017 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20081017 Address after: Delaware Patentee after: BPSI Holdings Inc. Address before: Delaware Patentee before: BPSI Holdings Inc. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Shanghai Colorcon Co., Ltd. Assignor: BPSI Holdings Inc. Contract fulfillment period: 2009.7.1 to 2014.12.31 Contract record no.: 2009990000921 Denomination of invention: Film coatings and film coating compositions based on polyvinyl alcohol Granted publication date: 20050615 License type: Exclusive license Record date: 20090813 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.7.1 TO 2014.12.31; CHANGE OF CONTRACT Name of requester: SHANGHAI COLORCON COATING TECHNOLOGY CO., LTD. Effective date: 20090813 |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20050615 |